- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Torrent Pharmaceuticals Limited — PPTs, 28-07-2025: Investor Presentation
**1. Financial Highlights:**
Torrent Pharma reported a solid 11% year-on-year growth in total consolidated revenues for Q1 FY26, reaching Rs 3,178 Cr, up from Rs 2,859 Cr in Q1 FY25. The India business led the charge with a robust 19% growth. Key markets like Germany, Brazil, and Others segments also showed strong double-digit growth at 11%, 10%, and 11% respectively, while the United States market grew 9%.
**2. Strategic Initiatives & Growth Drivers:**
No information provided in the attached document for this section.
**3. Business Developments:**
No information provided in the attached document for this section.
**4. Market Position & Competitive Advantage:**
No information provided in the attached document for this section.
**5. Investor Implications:**
The strong top-line performance, especially the impressive growth in the India market, indicates positive growth potential for Torrent Pharma. Investors should monitor continued revenue momentum across key geographies in future updates.